Assessing the Efficacy of Progesterone as a Therapeutic Agent  for Spinal Myelitis in Dogs: A Comprehensive Study

Authors

  • Ramkumar P K Veterinary Clinical Complex, Veterinary College and Research Institute (VCRI), Orathanadu- 614 625, Thanjavur, TANUVAS, India
  • M Saravanan Department of Veterinary Medicine, VCRI, Orathanadu-614 325, Thanjavur, TANUVAS, India
  • K Karthika Department of Veterinary Medicine, VCRI, Orathanadu-614 325, Thanjavur, TANUVAS, India
  • N Premalatha Department of Veterinary Preventive Medicine, Madras Veterinary College, TANUVAS, Chennai-600007, India
  • R Velusamy Department of Veterinary Parasitology, VCRI, Orathanadu-614 625, Thanjavur, TANUVAS, India
  • S Yogeshpriya Department of Veterinary Medicine, VCRI, Orathanadu-614 325, Thanjavur, TANUVAS, India

DOI:

https://doi.org/10.48165/ijvsbt.21.1.08

Keywords:

Glucocorticoid, Neuron specific enolase, Myelitis, Prednisolone, Progesterone

Abstract

This research focused on the treatment of confirmed neurological cases of myelitis in dogs. The control group (Group I) consisted of apparently healthy dogs of different breeds, ages, and sexes undergoing routine health check-ups. The study included Group II, treated with a standard glucocorticoid treatment protocol (n=6), and Group III, treated with progesterone (n=6). Parameters considered for analysis included breed, age, and sex of the animals. Clinical assessments involved recording of clinical signs, hematobiochemical analysis, cerebrospinal fluid (CSF) analysis, radiography. The selected cases underwent treatment with glucocorticoids as per standard protocol and were compared with those treated using progesterone. The treatment trial spanned a duration of 14 days. Evaluation of the treatment protocols included assessments of clinical recovery, hemato-biochemical changes, serum progesterone levels, and serum Neuron Specific Enolase levels on day 0 (pretreatment), 7th day, and 14th day post-treatment. CSF analysis, including progesterone assay, was conducted on day 0 and the 14th day post-treatment. The overall incidence of various neurological disorders causing ataxia in dogs was 2.38%. Among these cases, 59% were encephalitis, 24% were myelitis, and 17% were neuromyopathies. The progesterone treatment protocol exhibited significant therapeutic efficacy for myelitis (spinal cord injury) cases.

Downloads

Download data is not yet available.

References

Cahill, M.A. (2007). Progesterone receptor membrane component 1: An integrative view. Journal of Steroid Biochemistry and Molecular Biology, 105, 16-36.

Cornelis, I.N.E. (2017). Meningoencephalomyelitis of unknown aetiology in dogs: A diagnostic, therapeutic and prognostic challenge. Thesis, Ghent University. Faculty of Veterinary Medicine.

Deeks, E.D. (2011). 17 α-Hydroxyprogesterone Caproate (Makena™) in the prevention of preterm birth. Paediatrics Drugs, 13(5), 337-345.

Denny, H.R., & Butterworth, S J. (2000). A guide to canine and feline orthopaedic surgery. 4th edition. Blackwell Sciences Ltd., p. 175-182.

González-Orozco, J.C., & Camacho-Arroyo, I. (2019). Progesterone actions during central nervous system development. Frontiers in Neuroscience, 17(13), 503.

Guennoun, R. (2020). Progesterone in the brain: Hormone, neurosteroid and neuroprotectant. International Journal of Molecular Science, 21, 5271.

Hagg, T., & Oudega, M. (2006). Degenerative and spontaneous regenerative processes after spinal cord injury. Journal of Neurotrauma, 23(3-4), 264-280.

Kobrine, A.I., Doyle, T.F., & Martins, A.N. (1975). Autoregulation of spinal cord blood flow. Clinical Neurosurgery, 22, 573-581.

Mietto, B.S., Mostacada, K., & Martinez, A.M. (2015). Neurotrauma and inflammation: CNS and PNS responses. Mediators in Inflammation, 2015, 251204.

Rezk, N.A., & Ibrahim, A.M. (2013). Effects of methyl prednisolone in early ARDS. Egyptian Journal of Chest Diseases & Tuberculosis, 62(1), 167-172.

Root Kustritz, M.V. (2001). Use of supplemental progesterone in management of canine pregnancy. In: Recent Advances in Small Animal Reproduction. Concannon P.W., England G., Verstegen J. III, Linde Forsberg C., editors. IVIS, Ithaca, NY, USA.

Scott, H.W. (1997). Hemilaminectomy for the treatment of thoracolumbar disc disease in the dog: A follow-up study of 40 cases. Journal of Small Animal Practice, 38(11), 488-494.

Silverman, H.A., Chen, A., Kravatz, N.L., Chavan, S.S., & Chang, E.H. (2020). Involvement of Neural Transient Receptor Potential Channels in Peripheral Inflammation. Frontiers in Immunology, 11, 1-18.

Sivanarayanan, T.B. (2015). Evaluation of bone marrow derived mesenchymal stem cells and stem cell conditioned media for the repair of acute and subacute nerve injuries. Ph.D. Thesis Indian Veterinary Research Institute, Izatnagar, India

Snedecor, G.W. and Cochran, W.G. (1994). Statistical Methods. 8thedn., Iowa State University Press, Ames, Iowa, USA.

Sudhir, K.G. (2019). Evaluation of surgicotherapeutic approach in spinal disorders in dogs with posterior paresis and hindquarter weakness. Thesis. Maharashtra Animal and Fishery Sciences University, Nagpur, India

Published

2025-01-21

How to Cite

P K, R. ., M Saravanan, Karthika, K., Premalatha , . N., Velusamy, R., & Yogeshpriya, . S. (2025). Assessing the Efficacy of Progesterone as a Therapeutic Agent  for Spinal Myelitis in Dogs: A Comprehensive Study. Indian Journal of Veterinary Sciences and Biotechnology, 21(1), 35-41. https://doi.org/10.48165/ijvsbt.21.1.08